GB0808709D0 - New combination 295 - Google Patents

New combination 295

Info

Publication number
GB0808709D0
GB0808709D0 GBGB0808709.0A GB0808709A GB0808709D0 GB 0808709 D0 GB0808709 D0 GB 0808709D0 GB 0808709 A GB0808709 A GB 0808709A GB 0808709 D0 GB0808709 D0 GB 0808709D0
Authority
GB
United Kingdom
Prior art keywords
new combination
new
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0808709.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
AstraZeneca AB
Original Assignee
Argenta Discovery Ltd
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd, AstraZeneca AB filed Critical Argenta Discovery Ltd
Priority to GBGB0808709.0A priority Critical patent/GB0808709D0/en
Publication of GB0808709D0 publication Critical patent/GB0808709D0/en
Priority to PCT/SE2009/050524 priority patent/WO2009139707A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0808709.0A 2008-05-13 2008-05-13 New combination 295 Ceased GB0808709D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0808709.0A GB0808709D0 (en) 2008-05-13 2008-05-13 New combination 295
PCT/SE2009/050524 WO2009139707A1 (en) 2008-05-13 2009-05-12 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0808709.0A GB0808709D0 (en) 2008-05-13 2008-05-13 New combination 295

Publications (1)

Publication Number Publication Date
GB0808709D0 true GB0808709D0 (en) 2008-06-18

Family

ID=39571295

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0808709.0A Ceased GB0808709D0 (en) 2008-05-13 2008-05-13 New combination 295

Country Status (2)

Country Link
GB (1) GB0808709D0 (en)
WO (1) WO2009139707A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
WO2009138707A1 (en) 2008-05-13 2009-11-19 Astrazeneca Ab Quinuclidine derivatives as muscarinic m3 receptor antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR044134A1 (en) * 2003-05-02 2005-08-24 Novartis Ag DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS.
MX2008001067A (en) * 2005-08-01 2008-03-19 Astrazeneca Ab Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases.
TW200738635A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CN101553493B (en) * 2006-07-19 2012-07-04 阿斯利康(瑞典)有限公司 Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
TW200825084A (en) * 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521

Also Published As

Publication number Publication date
WO2009139707A1 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
IL208405A0 (en) Substituted pyrimidin-5-carboxamides 281
GB0811099D0 (en) New combination 376
GB0808709D0 (en) New combination 295
GB0905087D0 (en) Cypardon 2
GB0808710D0 (en) New combination 296
GB0808845D0 (en) 10000003
GB0808958D0 (en) 10000004
GB0809700D0 (en) Florierre 2400
GB0810603D0 (en) Corcost prepost 001
GB0813671D0 (en) Corcost prepost 2020
GB0818445D0 (en) Cocept 46
GB0808847D0 (en) 10000001
GB0808846D0 (en) 10000002
GB0807658D0 (en) Sebaforce 2
GB0808042D0 (en) Advance 002
GB0808551D0 (en) Note 200002
GB0808544D0 (en) Note 200010
GB0808545D0 (en) Note 200009
GB0808546D0 (en) Note 200008
GB0808547D0 (en) Note 200007
GB0808548D0 (en) Note 200005
GB0808549D0 (en) Note 200004
GB0808550D0 (en) Note 200003
GB0805897D0 (en) Note 10001
GB0808552D0 (en) Note 200006

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)